Gene Query: ITGAV

Dataset Description Geneva Score
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 62.27
Gene Expression Profiling of SPOP Knocked Down Cell 59.73
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 58.11
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 55.41
RNA-seq in transgenic cells 47.6
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 46.47
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 46.4
Expression data from miR340 overexpressing human A549 cells 45.39
Transcriptomic analysis of LSD1 44.65
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 43.42
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 43.25
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 43.25
An RNA-centric dissection of host complexes controlling flavivirus infection 42.65
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 42.65
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 41.98
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 41.96
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 41.38
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 40.66
Active translatome profiling with RiboLace in MCF7 cells 39.87
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 39.19
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 38.82
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 38.52
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 37.76
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 37.36
Differetially expressed genes after hTR overexpression in U2OS cells 35.94
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 35.25
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 34.85
Transcriptomic profiling of human peripheral blood-derived mast cells 34.85
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 32.58
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 32.55
hTERT promotes cell adhesion and migration independent of telomerase activity 31.87
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 31.45
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 31.28
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 30.92
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 29.31
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 28.91
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 28.76
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 28.55
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 28.42
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 28.41
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 28.29
Survival of pancreatic cancer cells lacking KRAS function 28.05
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 27.94
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 27.91
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 27.23
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 27.23
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 26.86
MEIS1 regulates hematopoiesis in hPSCs 26.73
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 26.69
Transcriptomic analysis of ERR alpha orphan nuclear receptor 26.67
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 26.32
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 26.32
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 26.2
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 26.2
DIGIT regulates endoderm differentiation of human embryonic stem cells 25.73
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 25.18
Genome-wide functional assessment of enhancer activities in the human genome 24.88
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 24.59
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 24.59
Modeling Familial Cancer with iPSC Approaches 24.43
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 24.41
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 24.41
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 24.41
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 24.25
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 24.19
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 24.02
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 23.92
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 23.62
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 23.57
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 23.57
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 22.8
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 22.73
Differential gene expression of human melanoma cells [RNA-seq] 22.61
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 22.61
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 22.58
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 22.5
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 22.5
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 22.31
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 22.08
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 22.08
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 21.92
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 21.84
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 21.83
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 21.83
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 21.33
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 21.24
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 21.24
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 21.17
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 20.85
High-throughput sequencing of PROMPT-enriched samples. 20.82
RNA-seq analysis of RALD iPSCs after in vitro differentiation 20.76
TCF7L1 knockdown in pancreatic cancer 20.62
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 20.57
Global expression profiles in cardiac progenitor cells generated by ISX-9 20.53
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 20.53
Reassessment of Exosome Composition 20.41
Transcriptome of Stabilin-1 siRNA transfected human monocytes 20.41
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 20.4
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 20.24
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 20.2
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 19.98
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 19.95
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 19.76
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 19.76
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 19.65
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 19.41
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 19.32
RNA expression analysis upon JMJD1C depletion 19.06
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 19.06
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 18.98
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 18.95
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 18.94
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 18.93
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 18.93
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 18.83
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 18.65
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 18.61
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 18.55
DJ-1 is dispensable for human stem cell homeostasis 18.44
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 18.35
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 18.28
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 18.28
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 18.25
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 18.16
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 17.97
Depicting early human development and germ cell origin with porcine embryos 17.9
The effect of insulin on mRNA transcription of human pluripotent stem cells 17.68
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 17.59
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 17.52
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 17.49
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 17.46
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 17.46
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 17.4
Gene expression profile of human iPSC-derived nephron progenitor cells 17.39
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 17.38
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 17.35
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 17.21
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 17.19
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 17.05
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 17.04
Non-coding regions are the main source of tumor-specific antigens [human] 17.0
Non-coding regions are the main source of tumor-specific antigens 17.0
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 16.93
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 16.64
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 16.49
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 16.38
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 16.35
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 16.31
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 16.26
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 16.22
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 16.18
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 16.14
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 16.14
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 15.92
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 15.73
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 15.73
miRNAs affected by antagomiR-17 treatment 15.58
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 15.49
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 15.45
Paxillin regulates genomic networks in prostate cancer [LNCaP] 15.44
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 15.44
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 15.41
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 15.38
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 15.36
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 15.29
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.27
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 15.17
METTL3 promotes translation in human cancer cells 15.13
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 15.11
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 15.07
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 15.07
Effects of rFVIIIFc on human macrophages 15.07
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 15.05
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 15.03
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.99
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 14.95
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 14.94
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 14.92
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 14.88
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 14.84
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 14.84
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 14.77
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 14.75
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 14.73
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 14.67
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 14.58
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 14.42
RNAseq of cell lines with knocked in ESR1 mutations 14.32
The effect of PPARG inhibition on human angiomyolipoma cells 14.31
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 14.2
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 14.2
Studying the selectivity of a small molecule Synucleozid on transcriptome 14.16
Functional role of SLIT2 and ROBO1 in trophoblasts 14.16
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 14.13
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 14.12
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 14.05
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 13.98
Functional Haploid Human Oocytes Generated from Polar Body Genomes 13.98
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 13.95
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 13.95
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 13.95
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 13.92
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 13.88
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 13.83
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 13.71
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 13.71
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 13.68
Co-regulation of splicing by Rbfox1 and hnRNP M 13.68
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 13.67
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 13.66
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 13.63
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 13.6
Transcriptomes of human monocytes after ex vivo exposure to uric acid 13.6
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 13.59
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 13.52
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 13.48
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 13.47
Postnatal lipids drive hepatocyte maturation 13.47
Proteomics identifies a marker signature of MAPKi resistance in melanoma 13.46
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 13.46
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 13.35
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 13.32
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 13.29
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 13.26
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 13.25
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 13.18
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 13.13
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 13.07
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 12.87
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 12.87
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 12.85
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 12.78
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 12.77
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 12.73
RNA sequencing with KSHV infection and enrichment for circular RNAs 12.61
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 12.32
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 12.32
LncRNA-GAS5 negative regulation of YAP-target genes expression 12.31
RNA-seq of tumor cells following angiopellosis extravasation 12.29
Gene expression analysis of the impact of TDP-43 knockout in human cells. 12.26
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 12.22
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 12.18
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 12.11
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 12.08
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 12.06
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 11.92
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 11.9
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 11.89
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 11.89
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 11.84
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 11.78
Aortic Valve Tissue: Stenosis vs. Sclerosis 11.77
Paxillin regulates genomic networks in prostate cancer [C4-2] 11.72
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 11.66
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 11.52
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 11.48
Transcriptome of U251 cells overexpression complement component 7 11.47
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 11.46
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 11.44
RNA-seq melanoma 11.44
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 11.44
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 11.44
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 11.29
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 11.29
RNA-seq of shEZH2 cells 11.22
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 11.2
Expression by CD133+ cells isolated from the adult human exocrine pancreas 11.15
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 11.11
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 11.11
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 11.1
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 11.1
EWS-Fli and LNC regulated genes in comparison to GFP samples 10.81
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 10.77
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 10.77
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 10.74
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 10.74
Fibroblasts in cholesteatoma activate osteoclasts. 10.63
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 10.52
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 10.5
Exploring the RNA landscape of endothelial exosomes 10.48
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 10.33
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 10.07
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.93
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 9.9
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 9.9
Recovery and analysis of nascent RNA 9.87
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 9.87
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 9.86
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 9.86
Induced DNA demethylation, genome instability and transcription 9.85
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 9.85
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 9.83
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 9.66
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 9.65
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 9.6
RNA sequencing of human mammary epithelial cells 9.58
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.54
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.54
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 9.52
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 9.47
RNA-seq of naive and primed ES cells (NHSM) 9.45
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 9.41
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 9.41
Effect of nuclear IL-33 on gene expression 9.36
A transcriptome-wide divergence in protein translation scales with LIN28B expression 9.34
Interaction between mitoNEET and NAF-1 in cancer cells 9.29
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 9.28
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 9.24
Transcriptome wide analysis of classically and alternatively activated macrophages 9.23
The transcriptome effect of overexpressing EZH2 in MCF7 9.15
RNA seq with AML (NB4) cells upon FTO inhibition 8.94
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 8.86
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 8.7
Generation and functional characterization of MDSC-like cells 8.68
Macrophage Ad5f35 M2 Challenge 8.62
mRNA-Seq profiling of human developing kidney 8.6
RNA seq_PDX2_SHP099 8.54
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 8.53
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 8.48
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 8.39
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 8.39
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 8.38
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 8.37
Exploring ILF2 regulatory genes by next-generation sequencing 8.27
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 8.22
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 8.1
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 8.1
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 8.06
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 8.06
KSDM1b Role in Ewing Sarcoma 7.95
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 7.95
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 7.89
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 7.68
ARID1A and ARID1B loss in HCT116 and TOV21G cells 7.54
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 7.49
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 7.42
MicroRNA targetome analysis during HCMV infection 7.4
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 7.34
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 7.28
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 7.28
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 7.24
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 7.15
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 7.13
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 7.07
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 7.06
Copper Regulation of HIF-1 Transcription Activity 7.06
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.99
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 6.99
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.91
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 6.9
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 6.85
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 6.85
RNA-seq analysis upon ARID1B overexpression 6.77
Gene Expression Profiling of WT and KDM3A Knocked out Cell 6.71
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 6.71
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 6.64
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 6.61
Gene expression profiling of KSHV-infected periodontal ligament cells 6.59
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 6.46
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 6.46
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.45
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 6.36
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 6.34
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 6.31
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 6.25
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 6.2
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 6.12
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 6.12
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.09
The contribution of Alu exons to the human proteome 5.9
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.82
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.82
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.79
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.63
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.43
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 5.35
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 5.27
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 5.26
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 5.26
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 5.24
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 5.13
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 5.01
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 5.0
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 4.96
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 4.93
Aneuploidy triggers an immune response 4.86
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 4.82
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 4.81
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.75
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 4.75
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.69
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.58
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.58
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.58
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 4.56
Gene expression profiling of papillary thyroid cancer from central and invasive regions 4.55
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 4.53
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.46
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 4.38
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 4.38
Mitochondrial dsRNA triggers antiviral signalling in humans 4.26
Transcriptome-wide modulation of splicing by the exon junction complex 4.25
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 4.14
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 4.1
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 4.06
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 4.06
Transcriptome analysis of peripheral blood monocytes 4.01
Regulatory network controlling tumor-promoting inflammation in human cancers 3.92
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.92
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 3.88
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 3.81
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.79
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.71
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 3.71
Ribosomal protein RPL26 is the principal target of UFMylation 3.69
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.56
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.42
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.41
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 3.39
Identification of differentially expressed genes between senescence and senescence bypass cells 3.35
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.33
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 3.31
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 3.3
Transcriptomes in healthy and CHB fetal hearts 3.23
RNA-seq analysis of control and Myc-induced U2OS cells 3.21
IMP3 regulated gene expression in breast cancer cells 3.19
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.11
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 2.99
miR-93 Targets in Human Endothelial Cells 2.94
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 2.91
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 2.89
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.88
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 2.88
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.87
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.85
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.71
Comparison of microRNA Profiling Platforms (HTS) 2.67
Comparison of microRNA Profiling Platforms 2.67
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.67
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.59
Measure transcript integrity using RNA-seq data 2.56
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 2.35
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.32
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.32
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.26
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.26
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.26
Exogenous rescue of KLHL9 in SF210 cell line 2.22
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.04
Disruption of GRIN2B impairs differentiation in human neurons 1.97
Hepatocyte maturation 1.96
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.95
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.87
AUF-1 affected genes in human skin cells 1.86
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.85
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.73
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.67
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.59
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.53
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.44
The role of the Calcium-Sensing receptor in colorectal cancer 1.44
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.44
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.36
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.31
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.28
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 1.13
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 1.13
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.12
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 1.1
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 1.1
Dilated cardiomyopathy vs Myocarditis 1.09
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.09
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.06
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.0
RNA-Seq of PRMT1 overexpression ECA109 cells 0.99
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.94
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.87
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.87
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.85
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.76
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.75
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 0.73
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.72
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.6
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.6
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.56
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.56
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.52
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.41
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.4
Transcriptome-wide response to synthetic chromatin protein PcTF 0.28
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.24
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.2
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.18
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.15
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.14
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.08
Effects of transcription on genome - nuclear lamina interactions 0.08
Preclinical model of obesity and ER-positive breast cancer 0.05
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation